| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000017881 |
| Receipt No. | R000018730 |
| Scientific Title | Association between vascular calcification and exostosin-like glycosaminotransferase 2 (EXTL2) in hemodialysis patients |
| Date of disclosure of the study information | 2015/06/15 |
| Last modified on | 2020/06/25 (Ver. 6) |
| Basic information | ||
| Public title | Association between vascular calcification and exostosin-like glycosaminotransferase 2 (EXTL2) in hemodialysis patients | |
| Acronym | Association between vascular calcification and EXTL2 | |
| Scientific Title | Association between vascular calcification and exostosin-like glycosaminotransferase 2 (EXTL2) in hemodialysis patients | |
| Scientific Title:Acronym | Association between vascular calcification and EXTL2 | |
| Region |
|
|
| Condition | ||
| Condition | Chronic Kidney Disease | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To investigate whether EXTL2 is associated with vascular calcification in hemodialysis patients |
| Basic objectives2 | Others |
| Basic objectives -Others | Association between EXTL2 and vascular calcification |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Association between EXTL2 and abdominal calcification index (ACI) |
| Key secondary outcomes | 1, Association between EXTL2 and chondroitin sulfate or heparan sulfate
2, Association between serum EXTL2 levels and EXTL2 mRNA in blood 3, Association between EXTL2 and other parameters 4, Difference of serum EXTL2 levels between healthy control and hemodialysis patients 5, Association between vascular calcification and chondroitin sulfate or heparan sulfate |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | hemodialysis patients | |||
| Key exclusion criteria | 1, Inpatients
2, Patients who started hemodialysis within 6 months 3, Diabetic patients 4, Patients whose diameter of abdominal aorta is over three centimeters 5, Patients with surgical history of abdominal aorta 6, Patients who do not agree with participation in this study |
|||
| Target sample size | 20 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Kobe University Graduate School of Medicine | ||||||
| Division name | Division of Nephrology and Kidney Center | ||||||
| Zip code | |||||||
| Address | 7-5-2, Kusuhoki-cho, Chuo-ku, Kobe, Japan | ||||||
| TEL | 078-382-6500 | ||||||
| sgoto@med.kobe-u.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Kobe University Graduate School of Medicine | ||||||
| Division name | Division of Nephrology and Kidney Center | ||||||
| Zip code | |||||||
| Address | 7-5-2, Kusuhoki-cho, Chuo-ku, Kobe, Japan | ||||||
| TEL | 078-382-6500 | ||||||
| Homepage URL | |||||||
| sgoto@med.kobe-u.ac.jp | |||||||
| Sponsor | |
| Institute | Division of Nephrology and Kidney Center, Kobe University Graduate School of Medicine |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Japanese Association of Dialysis Physicians |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | |
| Address | |
| Tel | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 社会医療法人愛仁会千船病院(大阪府) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | ||
| URL related to results and publications | ||
| Number of participants that the trial has enrolled | 27 | |
| Results | ||
| Results date posted | ||
| Results Delayed |
|
|
| Results Delay Reason | We require time to complete the paper. | |
| Date of the first journal publication of results | ||
| Baseline Characteristics | ||
| Participant flow | ||
| Adverse events | ||
| Outcome measures | ||
| Plan to share IPD | ||
| IPD sharing Plan description | ||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | Prospective study |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000018730 |